Rewiring of an epithelial differentiation factor, miR-203, to inhibit human squamous cell carcinoma metastasis

Cell Reports

Volumn 9, Issue 1, 2014, Pages 104-117

  Benaich, Nathan ^a,b   Woodhouse, Samuel ^b   Goldie, Stephen J ^a   Mishra, Ajay ^b   Quist, Sven R ^a,c   Watt, Fiona M ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MICRORNA; MICRORNA 203; OSTEONECTIN; PROTEIN LASP1; PROTEIN NUAK1; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; LASP1 PROTEIN, HUMAN; LIM PROTEIN; MIRN203 MICRORNA, HUMAN; NUAK1 PROTEIN, HUMAN; PROTEIN KINASE; REPRESSOR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SPARC PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL METABOLISM; COHORT ANALYSIS; CONTROLLED STUDY; CYTOSKELETON; DRUG TARGETING; EXTRACELLULAR MATRIX; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG METASTASIS; MAJOR CLINICAL STUDY; METASTASIS INHIBITION; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL DIFFERENTIATION; CELL MOTION; GENETICS; HEAD AND NECK TUMOR; LUNG NEOPLASMS; METABOLISM; METASTASIS; MOUSE; PATHOLOGY; PROGNOSIS; SECONDARY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; XENOGRAFT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETAL PROTEINS; HEAD AND NECK NEOPLASMS; HETEROGRAFTS; HUMANS; LIM DOMAIN PROTEINS; LUNG NEOPLASMS; MICE; MICRORNAS; NEOPLASM METASTASIS; OSTEONECTIN; PROGNOSIS; PROTEIN KINASES; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 84908011236     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.08.062     Document Type: Article

References (51)

1. Agrawal N., Frederick M.J., Pickering C.R., Bettegowda C., Chang K., Li R.J., Fakhry C., Xie T.X., Zhang J., Wang J., et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011, 333:1154-1157.
2. Aqeilan R.I., Calin G.A., Croce C.M. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ. 2010, 17:215-220.
3. Argiris A., Karamouzis M.V., Raben D., Ferris R.L. Head and neck cancer. Lancet 2008, 371:1695-1709.
4. Arwert E.N., Hoste E., Watt F.M. Epithelial stem cells, wound healing and cancer. Nat. Rev. Cancer 2012, 12:170-180.
5. Blanpain C., Fuchs E. Epidermal stem cells of the skin. Annu. Rev. Cell Dev. Biol. 2006, 22:339-373.
6. Chakrabarti R., Hwang J., Andres Blanco M., Wei Y., Lukačišin M., Romano R.A., Smalley K., Liu S., Yang Q., Ibrahim T., et al. Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nat. Cell Biol. 2012, 14:1212-1222.
7. Chang X.Z., Yu J., Liu H.Y., Dong R.H., Cao X.C. ARK5 is associated with the invasive and metastatic potential of human breast cancer cells. J.Cancer Res. Clin. Oncol. 2012, 138:247-254.
8. Chin D., Boyle G.M., Williams R.M., Ferguson K., Pandeya N., Pedley J., Campbell C.M., Theile D.R., Parsons P.G., Coman W.B. Novel markers for poor prognosis in head and neck cancer. Int. J. Cancer 2005, 113:789-797.
9. Cromer A., Carles A., Millon R., Ganguli G., Chalmel F., Lemaire F., Young J., Dembélé D., Thibault C., Muller D., et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 2004, 23:2484-2498.
10. Davis M.E., Chen Z.G., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 2008, 7:771-782.
11. Ding X., Park S.I., McCauley L.K., Wang C.-Y. Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis. J.Biol. Chem. 2013, 288:10241-10253.
12. Flores E.R., Sengupta S., Miller J.B., Newman J.J., Bronson R., Crowley D., Yang A., McKeon F., Jacks T. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 2005, 7:363-373.
13. Goldie S.J., Mulder K.W., Tan D.W.M., Lyons S.K., Sims A.H., Watt F.M. FRMD4A upregulation in human squamous cell carcinoma promotes tumor growth and metastasis and is associated with poor prognosis. Cancer Res. 2012, 72:3424-3436.
14. Hüsemann Y., Geigl J.B., Schubert F., Musiani P., Meyer M., Burghart E., Forni G., Eils R., Fehm T., Riethmüller G., Klein C.A. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13:58-68.
15. Jackson S.J., Zhang Z., Feng D., Flagg M., O'Loughlin E., Wang D., Stokes N., Fuchs E., Yi R. Rapid and widespread suppression of self-renewal by microRNA-203 during epidermal differentiation. Development 2013, 140:1882-1891.
16. Kim J.B., Urban K., Cochran E., Lee S., Ang A., Rice B., Bata A., Campbell K., Coffee R., Gorodinsky A., et al. Non-invasive detection of a small number of bioluminescent cancer cells invivo. PLoS ONE 2010, 5:e9364.
17. Kretz M., Webster D.E., Flockhart R.J., Lee C.S., Zehnder A., Lopez-Pajares V., Qu K., Zheng G.X., Chow J., Kim G.E., et al. Suppression of progenitor differentiation requires the long noncoding RNA ANCR. Genes Dev. 2012, 26:338-343.
18. Lapouge G., Beck B., Nassar D., Dubois C., Dekoninck S., Blanpain C. Skin squamous cell carcinoma propagating cells increase with tumour progression and invasiveness. EMBO J. 2012, 31:4563-4575.
19. Leemans C.R., Braakhuis B.J.M., Brakenhoff R.H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 2011, 11:9-22.
20. Liu L., Ulbrich J., Müller J., Wüstefeld T., Aeberhard L., Kress T.R., Muthalagu N., Rycak L., Rudalska R., Moll R., et al. Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature 2012, 483:608-612.
21. Lujambio A., Lowe S.W. The microcosmos of cancer. Nature 2012, 482:347-355.
22. Martello G., Rosato A., Ferrari F., Manfrin A., Cordenonsi M., Dupont S., Enzo E., Guzzardo V., Rondina M., Spruce T., et al. A MicroRNA targeting dicer for metastasis control. Cell 2010, 141:1195-1207.
23. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., Massagué J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524.
24. Mulder K.W., Wang X., Escriu C., Ito Y., Schwarz R.F., Gillis J., Sirokmány G., Donati G., Uribe-Lewis S., Pavlidis P., et al. Diverse epigenetic strategies interact to control epidermal differentiation. Nat. Cell Biol. 2012, 14:753-763.
25. Nguyen B.C., Lefort K., Mandinova A., Antonini D., Devgan V., Della Gatta G., Koster M.I., Zhang Z., Wang J., Tommasi di Vignano A., et al. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev. 2006, 20:1028-1042.
26. Nicolas M., Wolfer A., Raj K., Kummer J.A., Mill P., van Noort M., Hui C.C., Clevers H., Dotto G.P., Radtke F. Notch1 functions as a tumor suppressor in mouse skin. Nat. Genet. 2003, 33:416-421.
27. O'Donnell R.K., Kupferman M., Wei S.J., Singhal S., Weber R., O'Malley B., Cheng Y., Putt M., Feldman M., Ziober B., Muschel R.J. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 2005, 24:1244-1251.
28. Pantel K., Brakenhoff R.H. Dissecting the metastatic cascade. Nat. Rev. Cancer 2004, 4:448-456.
29. Pardal R., Clarke M.F., Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 2003, 3:895-902.
30. Png K.J., Halberg N., Yoshida M., Tavazoie S.F. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 2012, 481:190-194.
31. Reis P.P., Waldron L., Perez-Ordonez B., Pintilie M., Galloni N.N., Xuan Y., Cervigne N.K., Warner G.C., Makitie A.A., Simpson C., et al. A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence. BMC Cancer 2011, 11:437.
32. Rheinwald J.G., Beckett M.A. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 1981, 41:1657-1663.
33. Rhodes D.R., Kalyana-Sundaram S., Mahavisno V., Varambally R., Yu J., Briggs B.B., Barrette T.R., Anstet M.J., Kincead-Beal C., Kulkarni P., et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007, 9:166-180.
34. Rickman D.S., Millon R., De Reynies A., Thomas E., Wasylyk C., Muller D., Abecassis J., Wasylyk B. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays. Oncogene 2008, 27:6607-6622.
35. Saini S., Majid S., Yamamura S., Tabatabai L., Suh S.O., Shahryari V., Chen Y., Deng G., Tanaka Y., Dahiya R. Regulatory role of mir-203 in prostate cancer progression and metastasis. Clin. Cancer Res. 2011, 17:5287-5298.
36. Sen G.L., Reuter J.A., Webster D.E., Zhu L., Khavari P.A. DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature 2010, 463:563-567.
37. Sonkoly E., Lovén J., Xu N., Meisgen F., Wei T., Brodin P., Jaks V., Kasper M., Shimokawa T., Harada M., et al. MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma. Oncogenesis 2012, 1:e3.
38. Stransky N., Egloff A.M., Tward A.D., Kostic A.D., Cibulskis K., Sivachenko A., Kryukov G.V., Lawrence M.S., Sougnez C., McKenna A., et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333:1157-1160.
39. Suzuki A., Lu J., Kusakai G., Kishimoto A., Ogura T., Esumi H. ARK5 is a tumor invasion-associated factor downstream of Akt signaling. Mol. Cell. Biol. 2004, 24:3526-3535.
40. Taube J.H., Malouf G.G., Lu E., Sphyris N., Vijay V., Ramachandran P.P., Ueno K.R., Gaur S., Nicoloso M.S., Rossi S., et al. Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties. Sci Rep 2013, 3:2687.
41. Tiffen J.C., Bailey C.G., Ng C., Rasko J.E.J., Holst J. Luciferase expression and bioluminescence does not affect tumor cell growth invitro or invivo. Mol. Cancer 2010, 9:299.
42. Traenka C., Remke M., Korshunov A., Bender S., Hielscher T., Northcott P.A., Witt H., Ryzhova M., Felsberg J., Benner A., et al. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma. Cancer Res. 2010, 70:8003-8014.
43. Uhlen M., Oksvold P., Fagerberg L., Lundberg E., Jonasson K., Forsberg M., Zwahlen M., Kampf C., Wester K., Hober S., et al. Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 2010, 28:1248-1250.
44. Valastyan S., Weinberg R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.
45. Valastyan S., Benaich N., Chang A., Reinhardt F., Weinberg R.A. Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. Genes Dev. 2009, 23:2592-2597.
46. Valastyan S., Reinhardt F., Benaich N., Calogrias D., Szász A.M., Wang Z.C., Brock J.E., Richardson A.L., Weinberg R.A. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137:1032-1046.
47. Valastyan S., Chang A., Benaich N., Reinhardt F., Weinberg R.A. Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. Cancer Res. 2010, 70:5147-5154.
48. Valastyan S., Chang A., Benaich N., Reinhardt F., Weinberg R.A. Activation of miR-31 function in already-established metastases elicits metastatic regression. Genes Dev. 2011, 25:646-659.
49. Viticchiè G., Lena A.M., Latina A., Formosa A., Gregersen L.H., Lund A.H., Bernardini S., Mauriello A., Miano R., Spagnoli L.G., et al. MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 2011, 10:1121-1131.
50. Yi R., Poy M.N., Stoffel M., Fuchs E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 2008, 452:225-229.
51. * repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat. Cell Biol. 2013, 15:284-294.